Search Within

William K Kelly

  1. "Elsevier Science, Inc."
Formats
  1. Journal Article (20)
Groups
  1. Department of Medicine (13)
  2. Solid Tumor Oncology Division (13)
  3. Genitourinary Oncology Service (12)
  4. Biostatistics Service (4)
  5. Epidemiology and Biostatistics (4)
  6. Nursing (3)

More Groups

People
  1. Howard Scher (12)
  2. Glenn Heller (3)
  3. Caitlin Eicher (2)
  4. Charles Ryan (2)
  5. Harry Herr (2)
  6. James Eastham (2)

More People

Years
  1. 2009 (1)
  2. 2007 (1)
  3. 2004 (2)
  4. 2003 (3)
  5. 2002 (5)
  6. 1998 (2)

More Years

Publications
  1. Urology (13)
  2. Journal of Urology (5)
  3. European Urology (2)
Publishers
  1. Elsevier Science, Inc. (20)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
    Journal Article

    Morris, M. J.; Huang, D.; Kelly, W. K.; Slovin, S. F.; Stephenson, R. D.; Eicher, C.; Delacruz, A.; Curley, T.; Schwartz, L. H.; Scher, H. I.
    European Urology (2009)

    Fulltext@MSK | Save
  • A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Kelly, W. K.; Slovin, S.; Ryan, C.; Eicher, C.; Heller, G.; Scher, H. I.
    Journal of Urology (2007)

    Fulltext@MSK | Save
  • Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: Results of a phase I/II study
    Journal Article

    Konety, B. R.; Eastham, J. A.; Reuter, V. E.; Scardino, P. T.; Donat, S. M.; Dalbagni, G.; Russo, P.; Herr, H. W.; Schwartz, L.; Kantoff, P. W.; more...
    Journal of Urology (2004)

    Fulltext@MSK | Save
  • Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer
    Journal Article

    Ryan, C. J.; Zelefsky, M. J.; Heller, G.; Regan, K.; Leibel, S. A.; Scher, H. I.; Kelly, W. K.
    Urology (2004)

    Fulltext@MSK | Save
  • Cancer and Leukemia Group B (CALGB) 90203: A randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease
    Journal Article

    Eastham, J. A.; Kelly, W. K.; Grossfeld, G. D.; Small, E. J.
    Urology (2003)

    Fulltext@MSK | Save
  • Use of nomograms for predicting survival in patients with castrate prostate cancer
    Journal Article

    Galsky, M.; Kelly, W. K.
    Urology (2003)

    Fulltext@MSK | Save
  • Estimating survival benefit in castrate metastatic prostate cancer: Decision making in proceeding to a definitive phase III trial
    Journal Article

    Verbel, D. A.; Kelly, W. K.; Smaletz, O.; Regan, K.; Curley, T.; Heller, G.; Scher, H. I.
    Urology (2003)

    Fulltext@MSK | Save
  • Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer - Discussion
    Journal Article

    Smith, M. R.; D'Amico, A. V.; Kelly, W. K.; Pollack, A.
    Urology (2002)

    Fulltext@MSK | Save
  • Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer - Discussion
    Journal Article

    Lee, W. R.; Pollak, A.; Carroll, P. R.; Klotz, L.; D'Amico, A. V.; Kelly, W. K.; Sartor, O.; Kantoff, P. W.
    Urology (2002)

    Fulltext@MSK | Save
  • Editorial: States and state transitions are all that really matter
    Journal Article

    Scher, H. I.; Kelly, W. K.
    Journal of Urology (2002)

    Fulltext@MSK | Save